Pharmaceutical manufacturing
Produces antibiotics, analgesics and antipyretics, vitamins, haematinics, cardiovascular preparations, hypoglycemics, antiulcerants, and antifungals.
Source: LinkedIn company description · Retrieved October 13, 2026
Midpharma is a public shareholding company founded in 1993; production began by the end of 1997.
Midpharma currently produces antibiotics, analgesics and antipyretics, vitamins, haematinics, cardiovascular preparations, hypoglycemics, antiulcerants, and antifungals. Its production site comprises a general plant and a cephalosporin plant, with lines for tablets, capsules, aerosols, suppositories, ointments, liquids, dry suspensions, and counting.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its products are registered and actively sold in major Middle East and North African markets.
Produces antibiotics, analgesics and antipyretics, vitamins, haematinics, cardiovascular preparations, hypoglycemics, antiulcerants, and antifungals.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: October 8, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 16, 2026, September 29, 2026, October 8, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.